{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:04:12Z","timestamp":1790777052597,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.07.202","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T20:23:00Z","timestamp":1469910180000},"page":"303-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper"],"prefix":"10.1016","volume":"222","author":[{"given":"Dimitrios","family":"Farmakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuvia Ben","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candida","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Gotsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Guarracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Heunks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visnja","family":"Ivancan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Karavidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Kivikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Lomivorotov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Longrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Masip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Parkhomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Poelzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Pollesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Berg","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hynek","family":"Riha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Erik","family":"Ricksten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.G.","family":"Schwinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Birhan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzenna","family":"Zielinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.202_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2015.10.240","article-title":"Calcium sensitizers: what have we learned over the last 25years?","volume":"203","author":"Pollesello","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-007-9014-5","article-title":"Classical inotropes and new cardiac enhancers","volume":"12","author":"Parissis","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0015","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/0022-2828(95)90009-8","article-title":"Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan","volume":"27","author":"Haikala","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0735-1097(83)80009-6","article-title":"Regulation of myocardial contractility 1958\u20131983: an odyssey","volume":"1","author":"Katz","year":"1983","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0025","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","article-title":"Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium","volume":"98","author":"Hasenfuss","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00005344-199705000-00001","article-title":"Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy","volume":"29","author":"Pagel","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0035","doi-asserted-by":"crossref","first-page":"H914","DOI":"10.1152\/ajpheart.00465.2004","article-title":"Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure","volume":"288","author":"Tachibana","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0040","doi-asserted-by":"crossref","first-page":"H131","DOI":"10.1152\/ajpheart.2002.282.1.H131","article-title":"Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium","volume":"282","author":"Brixius","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1253\/jcj.65.451","article-title":"Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart","volume":"65","author":"Kawabata","year":"2001","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.106.668640","article-title":"Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships","volume":"115","author":"Givertz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjcard.2005.03.092","article-title":"Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure","volume":"96","author":"Parissis","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/FJC.0000000000000256","article-title":"Effect of levosimendan on diastolic function in patients undergoing coronary artery bypass grafting: a comparative study","volume":"66","author":"Malik","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.107.722868","article-title":"Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis","volume":"117","author":"J\u00f6rgensen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0070","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2004.02.052","article-title":"The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia","volume":"43","author":"Sonntag","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0075","first-page":"41","article-title":"Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl\/Rapp rats","volume":"60","author":"Louhelainen","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0080","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0707157","article-title":"Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl\/Rapp rats","volume":"150","author":"Louhelainen","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1742-7843.2011.00743.x","article-title":"Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats","volume":"109","author":"Vahtola","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0090","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/HJH.0b013e32832f0ce4","article-title":"Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats","volume":"27","author":"Louhelainen","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1476-5381.2010.00680.x","article-title":"Effects of the calcium sensitizer OR-1896, a metabolite of levosimendan, on post-infarct heart failure and cardiac remodelling in diabetic Goto-Kakizaki rats","volume":"160","author":"Louhelainen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejphar.2013.08.013","article-title":"Levosimendan inhibits interleukin-1\u03b2-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts","volume":"718","author":"Okada","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10557-005-5417-5","article-title":"Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure","volume":"19","author":"Tziakas","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/147323000503300405","article-title":"Effects of levosimendan on left ventricular functional remodelling and exercise intolerance: a tissue Doppler study","volume":"33","author":"Kasikcioglu","year":"2005","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1476-5381.2008.00024.x","article-title":"Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel","volume":"156","author":"Grossini","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2007.04.023","article-title":"Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure","volume":"197","author":"Parissis","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00789302","article-title":"Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency","volume":"91","author":"Pagel","year":"1996","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.CCM.0000257326.96342.57","article-title":"Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction","volume":"35","author":"Missant","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1399-6576.2007.01428.x","article-title":"Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy","volume":"51","author":"Guarracino","year":"2007","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0b013e3180986230","article-title":"The cardioprotective effects of levosimendan: preclinical and clinical evidence","volume":"50","author":"Pollesello","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjp.2008.52","article-title":"A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart","volume":"154","author":"du Toit","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vph.2007.06.008","article-title":"Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model","volume":"47","author":"Das","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.fjc.0000246151.39758.2a","article-title":"Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model","volume":"48","author":"Lepr\u00e1n","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.202_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00395-009-0064-9","article-title":"Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition","volume":"105","author":"H\u00f6nisch","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-6576.2009.02070.x","article-title":"Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs","volume":"54","author":"Metzsch","year":"2010","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0170","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/bja\/ael082","article-title":"Preconditioning effects of levosimendan in coronary artery bypass grafting\u2014a pilot study","volume":"96","author":"Tritapepe","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.echo.2005.08.016","article-title":"Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study","volume":"19","author":"De Luca","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0180","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1213\/01.ane.0000244326.38206.a0","article-title":"The vasodilatory effects of levosimendan on the human internal mammary artery","volume":"103","author":"Montes","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1742-7843.2011.00801.x","article-title":"Prolonged antispasmodic effect in isolated radial artery graft and pronounced platelet inhibition induced by the inodilator drug, levosimendan","volume":"110","author":"Ambrus","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1160\/TH14-06-0549","article-title":"Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro","volume":"113","author":"Krychtiuk","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0195","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/cc10307","article-title":"Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study","volume":"15","author":"Hasslacher","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2004.01.073","article-title":"Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure","volume":"93","author":"Parissis","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0205","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/hrt.2005.079707","article-title":"Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure","volume":"92","author":"Parissis","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0210","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.atherosclerosis.2007.07.011","article-title":"Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure","volume":"195","author":"Parissis","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0215","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejheart.2006.03.003","article-title":"Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure","volume":"8","author":"Trikas","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.112.193961","article-title":"Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs","volume":"342","author":"Grossini","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1510\/icvts.2007.161356","article-title":"The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study","volume":"7","author":"Yakut","year":"2008","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0748233712451773","article-title":"Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats","volume":"30","author":"Gecit","year":"2014","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0235","doi-asserted-by":"crossref","first-page":"F1453","DOI":"10.1152\/ajprenal.00485.2005","article-title":"Levosimendan protects against experimental endotoxemic acute renal failure","volume":"290","author":"Zager","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0240","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","article-title":"Renal effects of levosimendan: a consensus report","volume":"27","author":"Yilmaz","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0245","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1097\/CCM.0b013e31828e946a","article-title":"Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study","volume":"41","author":"Bragadottir","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.jvca.2013.09.004","article-title":"Levosimendan improves renal outcome in cardiac surgery: a randomized trial","volume":"28","author":"Baysal","year":"2014","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ejhf.9","article-title":"Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms","volume":"16","author":"Fedele","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0260","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/ctr.12424","article-title":"The effects of levosimendan on renal function early after heart transplantation: results from a pilot randomized trial","volume":"28","author":"Knezevic","year":"2014","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/FJC.0000000000000028","article-title":"Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis","volume":"63","author":"Niu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ajkd.2015.09.015","article-title":"Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"67","author":"Zhou","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0275","first-page":"35","article-title":"Lomivorotov V6, Calabr\u00f2 MG. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials","volume":"7","author":"Bove","year":"2015","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0280","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10557-007-6066-7","article-title":"Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine","volume":"21","author":"Yilmaz","year":"2007","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/1755-5922.12001","article-title":"Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction","volume":"31","author":"Hou","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0290","article-title":"Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment","volume":"31","author":"Rafouli-Stergiou","year":"2015","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2007.03.005","article-title":"Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation","volume":"13","author":"Zemljic","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0300","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/lt.23799","article-title":"Protective effects elicited by levosimendan against liver ischemia\/reperfusion injury in anesthetized rats","volume":"20","author":"Grossini","year":"2014","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124742","article-title":"Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis\/autophagy interplay","volume":"10","author":"Grossini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073758","article-title":"Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?","volume":"8","author":"Onody","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0315","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2014.07.047","article-title":"Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury","volume":"741","author":"Ibrahim","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0320","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0325","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/SHK.0b013e3181cd8c5b","article-title":"Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock","volume":"34","author":"Garc\u00eda-Septien","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0330","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0310057X1304100606","article-title":"A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study","volume":"41","author":"Alvarez","year":"2013","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2011.06.008","article-title":"The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock","volume":"27","author":"Memi\u015f","year":"2012","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.CCM.0000150653.89451.6F","article-title":"Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs","volume":"33","author":"Schwarte","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00134-006-0519-5","article-title":"Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study","volume":"33","author":"Dubin","year":"2007","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0350","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1213\/ane.0b013e3181af3fe3","article-title":"Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion","volume":"109","author":"Cunha-Goncalves","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0355","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1399-6576.2008.01659.x","article-title":"Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery","volume":"52","author":"Leppikangas","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0360","article-title":"Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0365","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s12013-014-0107-1","article-title":"Effects and mechanism analysis of combined infusion by levosimendan and vasopressin on acute lung injury in rats septic shock","volume":"70","author":"Wang","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0370","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.acthis.2008.09.010","article-title":"Effects of levosimendan and dobutamine on experimental acute lung injury in rats","volume":"111","author":"Erb\u00fcy\u00fcn","year":"2009","journal-title":"Acta Histochem."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0375","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jss.2014.08.038","article-title":"The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced","volume":"193","author":"Alkan","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jss.2007.08.002","article-title":"Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model","volume":"147","author":"Yasa","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0385","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/CCM.0b013e3181743e63","article-title":"Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury","volume":"36","author":"Boost","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066195","article-title":"Levosimendan relaxes pulmonary arteries and veins in precision-cut lung slices \u2014 the role of KATP-channels, cAMP and cGMP","volume":"8","author":"Rieg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0395","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/01.CCM.0000230244.17174.4F","article-title":"Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study","volume":"34","author":"Morelli","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1164\/rccm.200502-262OC","article-title":"Diaphragm dysfunction in chronic obstructive pulmonary disease","volume":"172","author":"Ottenheijm","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1164\/rccm.200805-732OC","article-title":"Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease","volume":"179","author":"van Hees","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0410","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-015-0798-8","article-title":"Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice","volume":"19","author":"Schellekens","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0415","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201107-1268OC","article-title":"The calcium sensitizer levosimendan improves human diaphragm function","volume":"185","author":"Doorduin","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2377-10-97","article-title":"Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury","volume":"10","author":"Roehl","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0425","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2377-13-106","article-title":"Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model","volume":"13","author":"Hein","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1540-8191.2007.00486.x","article-title":"Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping","volume":"23","author":"Katircioglu","year":"2008","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0435","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2377-12-81","article-title":"The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia\/hypoxia","volume":"12","author":"Roehl","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0440","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000314955","article-title":"Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study","volume":"99","author":"Bravo","year":"2011","journal-title":"Neonatology"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0445","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.curtheres.2015.01.001","article-title":"Oral levosimendan increases cerebral blood flow velocities in patients with a history of stroke or transient ischemic attack: a pilot safety study","volume":"77","author":"Kivikko","year":"2015","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0450","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajem.2015.11.024","article-title":"Role of levosimendan in the management of subarachnoid hemorrhage","volume":"34","author":"Varvarousi","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0455","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/02699051003789260","article-title":"Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study","volume":"24","author":"Cengiz","year":"2010","journal-title":"Brain Inj."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0460","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1097\/TA.0b013e31817c4284","article-title":"Levosimendan in cardiac failure after subarachnoid hemorrhage","volume":"68","author":"Busani","year":"2010","journal-title":"J. Trauma"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0465","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Heart Failure Association of the European Society of Cardiology. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0470","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjcard.2004.11.033","article-title":"Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone","volume":"95","author":"Nanas","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0475","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00392-013-0554-5","article-title":"Intermittent levosimendan treatment in patients with severe congestive heart failure","volume":"102","author":"Tuomainen","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0480","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FJC.0b013e31826b86aa","article-title":"Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival","volume":"60","author":"Malfatto","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0485","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijcard.2011.03.013","article-title":"Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure","volume":"159","author":"Bonios","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0490","first-page":"269","article-title":"Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period","volume":"50","author":"Papadopoulou","year":"2009","journal-title":"Hell. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0495","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0b013e31819846cd","article-title":"Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure","volume":"53","author":"Drakos","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0500","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0091270008325150","article-title":"Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study","volume":"49","author":"Kleber","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0505","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.hlc.2007.10.014","article-title":"Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure \u2014 a single-centre experience","volume":"17","author":"Parle","year":"2008","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0510","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cardfail.2007.04.004","article-title":"A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure","volume":"13","author":"Mavrogeni","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0515","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","article-title":"Repeated or intermittent levosimendan treatment in advanced heart failure: an updated meta-analysis","volume":"202","author":"Silvetti","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0520","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00392-013-0649-z","article-title":"Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials","volume":"103","author":"Silvetti","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0525","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.118","article-title":"Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial","volume":"16","author":"Altenberger","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0530","unstructured":"Nieminen MS, Altenberger J, Ben-Gal T, B\u00f6hmer A, Comin-Colet J, Dickstein K, Edes I, Fedele F, Fonseca C, Garc\u00eda-Gonz\u00e1lez MJ1, Giannakoulas G, Iakobishvili Z, J\u00e4\u00e4skel\u00e4inen P, Karavidas A, Kettner J, Kivikko M, Lund LH, Matskeplishvili ST, Metra M, Morandi F, Oliva F, Parkhomenko A, Parissis J, Pollesello P, P\u00f6lzl G, Schwinger RH, Segovia J, Seidel M, Vrtovec B, Wikstr\u00f6m G. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. Int. J. Cardiol. 2014;174:360\u20137."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0535","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s13054-014-0652-4","article-title":"Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model","volume":"18","author":"Tsao","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0540","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/01.CCM.0000261889.18102.84","article-title":"Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone","volume":"35","author":"Barraud","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0545","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10753-011-9388-3","article-title":"Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock","volume":"35","author":"Ji","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0550","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.resuscitation.2005.08.002","article-title":"Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study","volume":"69","author":"Dubin","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0555","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1097\/CCM.0000000000001269","article-title":"Anti-inflammatory profile of levosimendan in cecal ligation-induced septic mice and in lipopolysaccharide-stimulated macrophages","volume":"43","author":"Wang","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0560","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/bjp.2008.328","article-title":"Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli","volume":"155","author":"Sareila","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0565","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","article-title":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials","volume":"30","author":"Zangrillo","year":"2015","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0570","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","article-title":"Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression","volume":"31","author":"Morelli","year":"2005","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0575","doi-asserted-by":"crossref","first-page":"R232","DOI":"10.1186\/cc9387","article-title":"Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study","volume":"14","author":"Morelli","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0580","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biochi.2014.03.006","article-title":"Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial","volume":"102","author":"Torraco","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0585","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1745-6215-15-199","article-title":"An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial","volume":"15","author":"Orme","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0590","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.jvca.2011.09.006","article-title":"Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients","volume":"26","author":"Lomivorotov","year":"2012","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0595","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bja\/aeq402","article-title":"Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery","volume":"106","author":"Leppikangas","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0600","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00246-009-9571-6","article-title":"Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome","volume":"31","author":"Di Chiara","year":"2010","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0605","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.jvca.2008.02.019","article-title":"A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction","volume":"22","author":"De Hert","year":"2008","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0610","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/01.ane.0000256863.92050.d3","article-title":"The effects of levosimendan in cardiac surgery patients with poor left ventricular function","volume":"104","author":"De Hert","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0615","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-200412000-00013","article-title":"Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study","volume":"44","author":"Barisin","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0620","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ejcts.2007.07.010","article-title":"Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use","volume":"32","author":"Tasouli","year":"2007","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0625","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2015.02.022","article-title":"Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion","volume":"184","author":"Toller","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0630","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/138945009789108819","article-title":"Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function?","volume":"10","author":"Morelli","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijcard.2016.07.202_bb0635","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4614-1566-4_34","article-title":"Pharmacologic interventions to improve splanchnic oxygenation during ventilation with positive end-expiratory pressure","volume":"737","author":"Fournell","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0640","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2015.10.172","article-title":"The medical and socioeconomic burden of heart failure: a comparative delineation with cancer","volume":"203","author":"Farmakis","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0645","first-page":"92","article-title":"Levosimendan in lung transplant recipients with difficult weaning from ECMO","volume":"81","author":"Feltracco","year":"2015","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0650","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MAT.0b013e3182a4b32e","article-title":"Levosimendan may improve weaning outcomes in venoarterial ECMO patients","volume":"59","author":"Affronti","year":"2013","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0655","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2008.10.029","article-title":"Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function","volume":"87","author":"Eriksson","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0660","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ijcard.2014.08.039","article-title":"Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure","volume":"176","author":"Papanikolaou","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.202_bb0665","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00134-013-2945-5","article-title":"Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock","volume":"39","author":"Taccone","year":"2013","journal-title":"Intensive Care Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:02:15Z","timestamp":1568232135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316315972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":133,"alternative-id":["S0167527316315972"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.202","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}